Denali Therapeutics Inc (DNLI) — Strategic Asset Allocation Index
Denali Therapeutics Inc (DNLI) has a Strategic Asset Allocation Index of 2.7% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $24.70 Million) total $24.70 Million, measured against net assets of $926.20 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Denali Therapeutics Inc Strategic Asset Allocation Index (2016–2024)
This chart shows how Denali Therapeutics Inc's Strategic Asset Allocation Index has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the index stands at 2.7%, representing strategic assets of $24.70 Million against net assets of $926.20 Million USD. Explore DNLI cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Denali Therapeutics Inc (2016–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Denali Therapeutics Inc from 2016 to 2024, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Denali Therapeutics Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 29.2% | $359.37 Million | $- | $359.37 Million | $1.23 Billion | ▲ +29.2 pp |
| 2023 | 0.0% | $0.00 | $- | $0.00 | $1.03 Billion | ▼ -7.1 pp |
| 2022 | 7.1% | $74.52 Million | $74.52 Million | $0.00 | $1.04 Billion | ▼ -44.3 pp |
| 2021 | 51.4% | $495.06 Million | $69.61 Million | $425.45 Million | $962.29 Million | ▲ +45.1 pp |
| 2020 | 6.4% | $73.55 Million | $40.85 Million | $32.70 Million | $1.15 Billion | ▼ -24.1 pp |
| 2019 | 30.5% | $120.54 Million | $80.66 Million | $39.89 Million | $394.89 Million | ▼ -1.1 pp |
| 2018 | 31.6% | $173.04 Million | $25.16 Million | $147.88 Million | $546.85 Million | ▲ +15.3 pp |
| 2017 | 16.4% | $76.17 Million | $14.92 Million | $61.25 Million | $465.80 Million | ▼ -18.4 pp |
| 2016 | 34.7% | $88.34 Million | $15.26 Million | $73.08 Million | $254.52 Million | — |